About KEEP

Pharma has never had a window into the home.
We built one.

Every important decision a patient makes about their therapy happens at home. Not in the clinic. Not in a focus group. At home, in ordinary moments that nobody in pharma has ever been present for.

KEEP was built on a single conviction: that understanding what actually happens in those moments is not just possible. It is the only way to build a real relationship between pharma and the people they serve.

We are not the reconstruction of a day in the life of patients. We are the day.

What We Believe

Three things that haven't changed since day one.

We built KEEP around beliefs that most of the industry would push back on. We still hold them. They are why the work is worth doing.

Present beats retrospective. Always.

Every insight tool pharma relies on was built to reconstruct experience after it happened. Surveys, claims data, ad boards. They all look backward. Being present for experience as it unfolds is not an incremental improvement. It is a different category of understanding. We have never compromised on this, even when it cost us deals.

The intelligence has to compound.

A single report tells you what patients said once. Twelve months of continuous listening tells you what changed, when it changed, and why it matters. That is the only version of insight a brand team can actually act on. Everything we build is designed to get better with time, not reset every engagement.

The relationship has to be real.

Patients share what they actually think when the relationship earns it. The arm's-length structure between KEEP and the brand is not a compliance mechanism. It is the reason the intelligence is trustworthy. The moment you use that relationship to serve the brand instead of the patient, you corrupt the only thing that makes the work valuable.

The Team

Built by people who have lived on both sides of this problem.

We have built and scaled health tech companies, led commercial teams at global pharma, built software for the most regulated environments in the world, and lived personally with what it means when the system fails at home. That combination is not accidental.

Philip Wilkins

Founder & Co-CEO

Built KEEP after a personal health crisis showed him firsthand how completely the system loses sight of patients the moment they leave the clinic. Has spent his career building commercial relationships in life sciences and financial services. Believes the most important decisions in any business get made in the spaces between data.

Jeff Wandzura, RPh

Co-CEO

Pharmacist first, which means he understands what happens to a therapy plan the moment a patient walks out of the pharmacy. That gap between clinical intent and patient reality is what KEEP is built to close. He brings the clinical credibility that makes pharma teams listen.

Roy Bernhard

CTO

Has built software in environments where failure is not an option — regulated industries where data integrity, patient safety, and compliance are non-negotiable. Knows how to build things that actually work at scale, and what it costs when they don't.

Matt Vidito

VP, Enterprise Sales

Has sat across the table from pharma commercial teams long enough to know exactly what they need and what they're being sold that doesn't deliver it. Focuses on making sure the intelligence KEEP produces actually gets used — by the right people, at the right moment, in a way that changes decisions.

Chaz Mee

VP, Product

20+ years building digital product and experience systems for global brands including Nike, Microsoft, Goldman Sachs, Samsung, and P&G. Has launched AI-driven platforms at scale. Brings the discipline of consumer product design to a space that has rarely benefited from it.

Why This Matters

The intelligence only works because the relationship earns it.

We said it in the opening line: we are the day. Not a reconstruction of it. That is only possible because patients choose to let us be present. They don't have to. They do because the relationship is genuine and their privacy is real.

The why

Privacy is not a compliance checkbox. It is the foundation of everything.

The moment a patient feels observed rather than supported, they stop saying what they actually think. They start performing. And the moment they start performing, the intelligence becomes worthless.

We protect patient privacy with the same conviction we bring to everything else in this company. Not because we have to. Because the work depends on it. A patient who trusts the system will tell you things no survey will ever surface. That is the only version of insight worth having.

The how

What it means in practice.

Every patient in the KEEP network participates by choice, with full consent, and with the knowledge that their privacy is non-negotiable. What they share is never tied to their identity. It is never used against them.

What the brand team receives is de-identified and aggregated. No individual patient is identifiable in any output. KEEP sees conversation patterns across a population. The brand team sees what those patterns mean for their therapeutic area. The distance between those two things is deliberate. It is what makes patients willing to say what they actually think.

Opt-in only

Full consent before any engagement begins. Opt out at any time, no friction.

De-identified, always

No individual is identifiable in any output. Population-level intelligence only.

Used to represent, never to harm

What patients share builds better support and smarter strategy. Never against them.

Arm's-length by design

KEEP's separation from the brand is intentional. It is what makes patients speak freely.

Built on patient trust and consent. Designed around patient voice.